Cargando…

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

OBJECTIVE(S): The ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. The aim of this study was to evaluate the uptake of 18F-fluorothymidine (FLT) PET in renal cell carcinoma (RCC), and to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Peter K., Lee, Sze Ting, Murone, Carmel, Eng, John, Lawrentschuk, Nathan, Berlangieri, Salvatore U., Pathmaraj, Kunthi, O’Keefe, Graeme J., Sachinidis, John, Byrne, Amanda J., Bolton, Damien M., Davis, Ian D., Scott, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Oceania Journal of Nuclear Medicine & Biology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937709/ https://www.ncbi.nlm.nih.gov/pubmed/27408853

Ejemplares similares

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
por: Lee, Sze Ting, et al.
Publicado: (2021)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

(18)F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
por: Wieder, Hinrich, et al.
Publicado: (2018)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

(18)F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
por: Chandrasekaran, Sanjay, et al.
Publicado: (2013)

[(18)F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma
por: Holter, Jennifer L., et al.
Publicado: (2011)

Evaluation of limited blood sampling population input approaches for kinetic quantification of [(18)F]fluorothymidine PET data
por: Contractor, Kaiyumars B, et al.
Publicado: (2012)

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin
por: Boktor, Raef R., et al.
Publicado: (2022)

[(18)F]fluorothymidine and [(18)F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma
por: Anton-Rodriguez, Jose M., et al.
Publicado: (2019)

Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation
por: Ayati, Narjess, et al.
Publicado: (2017)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Pilot study assessing (18)F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation()
por: Cho, Linda P., et al.
Publicado: (2015)

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
por: Wondergem, Marielle J, et al.
Publicado: (2014)

Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
por: Greening, David W., et al.
Publicado: (2015)

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
por: Greening, David W., et al.
Publicado: (2016)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Preclinical Applications of 3'-Deoxy-3'-[(18)F]Fluorothymidine in Oncology - A Systematic Review
por: Schelhaas, Sonja, et al.
Publicado: (2017)

(18)F-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI
por: Zhao, Fen, et al.
Publicado: (2015)

The Influence of Interpreters’ Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using( 18)F-3′-Deoxy-Fluorothymidine and (18)F-Fluorodeoxyglucose PET/CT
por: Xu, Bai-xuan, et al.
Publicado: (2013)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
por: Kairemo, Kalevi, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
por: Romine, Perrin E., et al.
Publicado: (2021)

[(18)F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm
por: Gandhi, Richa, et al.
Publicado: (2021)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

(18)F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study
por: Christensen, Tine Nøhr, et al.
Publicado: (2020)

Mismatched intratumoral distribution of [(18)F] fluorodeoxyglucose and 3′-deoxy-3′-[(18)F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2017)

Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3′-deoxy-3′-[18F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2018)

First clinical study of a pegylated diabody (124)I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers
por: Scott, Andrew M., et al.
Publicado: (2020)

Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy
por: Carlin, Dominic, et al.
Publicado: (2019)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on (68)GA PSMA‐PET/CT
por: Bolton, Damien, et al.
Publicado: (2022)

(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

New Approaches to Targeting Epigenetic Regulation in Bladder Cancer
por: Thompson, Daryl, et al.
Publicado: (2023)

Bottom-of-sulcus dysplasia: the role of (18)F-FDG PET in identifying a focal surgically remedial epileptic lesion
por: Berlangieri, S. U., et al.
Publicado: (2020)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Exploratory Analysis of (18)F-3’-deoxy-3’-fluorothymidine ((18)F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
por: Fantini, Lorenzo, et al.
Publicado: (2021)

Prevention of sepsis prior to prostate biopsy
por: Toner, Liam, et al.
Publicado: (2016)

3′-Deoxy-3′-[(18)F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer
por: McKinley, Eliot T., et al.
Publicado: (2014)

Relative skeletal distribution of proliferating marrow in the adult dog determined using 3′‐deoxy‐3′‐[(18)F]fluorothymidine
por: Rowe, Joshua A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_33rasacnoh6qfvgceffove4qrd